▼ FY 2024 Summary Analysis
Annual report ending Dec 31, 2024Overview and Growth
Fiscal 2024 results for WINDTREE THERAPEUTICS INC /DE/ included net loss of $1.79M. At period end, total assets were $27.88M, framing the scale of the company’s operating and financing commitments.Profitability
The company recorded an operating loss of $26.14M after the reported operating expense base. The company ended the period with a net loss of $1.79M, extending the operating result through all remaining items. EBITDA was negative $26.05M, showing a deficit before interest, taxes, depreciation, and amortization. The pretax result was a loss of $1.79M, establishing the deficit before tax effects. The reported tax benefit was $6.00K, favorably bridging the pretax and after-tax results. The loss-to-equity relationship was 17.9%, placing the bottom-line deficit against shareholder capital. The net loss equaled 6.4% of period-end assets, showing the deficit relative to the asset base. The bottom-line deficit decreased from $20.29M in fiscal 2023 to $1.79M.Liquidity and Capital Structure
Total assets were $27.88M, supported by $14.70M of liabilities and $10.00M of shareholder equity. At period end, current assets of $2.57M compared with current liabilities of $5.72M, defining the company’s short-term resource position. At 0.45x, current liabilities exceeded current assets and placed pressure on the company’s near-term liquidity position. The company held $1.78M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 31.1% of current liabilities, showing how much near-term coverage came from cash alone. Book equity represented 35.9% of total assets, quantifying the balance-sheet share supported by shareholder capital. The liabilities-to-assets relationship was 52.7%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 6.4%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $32.41M in fiscal 2023, the current asset base moved 14.0% and finished lower. Against $3.39M of equity in fiscal 2023, the current book-equity balance moved 194.8% and ended higher. The reported cash balance changed 58.8% from $4.32M in fiscal 2023, ending lower year over year.Cash Flow and Earnings Quality
The company reported an operating cash outflow of $15.40M, rather than cash generation from operations. Capital expenditures used $12.00K in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. The company recorded a $15.41M cash deficit after capital spending for the period. The cash deficit after capital spending represented 55.3% of the period-end asset base. The operating cash outflow widened to $15.40M from $13.44M in fiscal 2023.
Based on the annual report for the fiscal year ending Dec 31, 2024.
Analysis generated .
Fundamentals Hub